Cargando…

Carotid Artery Stenting in Patients with Symptomatic and Asymptomatic Stenosis: In-Hospital Clinical Outcomes at a Single Neurovascular Center

Background: Carotid artery stenting (CAS) is a minimally invasive and proven percutaneous procedure that is widely used to treat patients with symptomatic and asymptomatic carotid artery stenosis. The purpose of this study was to characterize the in-hospital outcomes of symptomatic and asymptomatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Hajiyev, Kamran, Hellstern, Victoria, Cimpoca, Alexandru, Wendl, Christina, Bäzner, Hansjörg, Henkes, Hans, von Gottberg, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031352/
https://www.ncbi.nlm.nih.gov/pubmed/35456179
http://dx.doi.org/10.3390/jcm11082086
_version_ 1784692368914513920
author Hajiyev, Kamran
Hellstern, Victoria
Cimpoca, Alexandru
Wendl, Christina
Bäzner, Hansjörg
Henkes, Hans
von Gottberg, Philipp
author_facet Hajiyev, Kamran
Hellstern, Victoria
Cimpoca, Alexandru
Wendl, Christina
Bäzner, Hansjörg
Henkes, Hans
von Gottberg, Philipp
author_sort Hajiyev, Kamran
collection PubMed
description Background: Carotid artery stenting (CAS) is a minimally invasive and proven percutaneous procedure that is widely used to treat patients with symptomatic and asymptomatic carotid artery stenosis. The purpose of this study was to characterize the in-hospital outcomes of symptomatic and asymptomatic patients undergoing CAS at a single neurovascular center. Methods: The study was conducted as a retrospective analysis of 1158 patients (asymptomatic, n = 636; symptomatic, n = 522; male, n = 816; median age, 71 years; NASCET method, 70–99% stenosis, n = 830) who underwent CAS between May 2009 and December 2020. In-hospital neurological outcomes, adverse reactions to iodinated contrast media, acute myocardial infarction, intraprocedural complications, and access-site issues were evaluated. The primary endpoints were disabling stroke (including disabling cerebral hyperperfusion syndrome [CHS]) and all in-hospital deaths. Results: A carotid stent could not be deployed in one patient due to calcified plaques (technical failure rate of 0.09%). Four patients (0.3%) experienced in-hospital, stroke-associated death, while five patients (0.4%) died from non-stroke-related causes. All stroke-associated deaths occurred in the symptomatic group and were due to CHS. The disabling stroke rate was 0.9% overall (n = 10; 0.5% versus 1.3% in asymptomatic versus symptomatic patients, respectively). Nineteen patients (1.6%) reached the in-hospital primary endpoint. More patients in the symptomatic group achieved this endpoint than in the asymptomatic group (2.5% versus 0.9%, respectively; p = 0.060). Conclusions: An evaluation was conducted on the in-hospital outcomes of 1158 patients at a single center who underwent CAS and was performed by trained physicians who were supervised by a senior neurovascular interventionist with over 20 years of experience, confirming the excellent safety profile of this procedure with a low rate of complications.
format Online
Article
Text
id pubmed-9031352
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-90313522022-04-23 Carotid Artery Stenting in Patients with Symptomatic and Asymptomatic Stenosis: In-Hospital Clinical Outcomes at a Single Neurovascular Center Hajiyev, Kamran Hellstern, Victoria Cimpoca, Alexandru Wendl, Christina Bäzner, Hansjörg Henkes, Hans von Gottberg, Philipp J Clin Med Article Background: Carotid artery stenting (CAS) is a minimally invasive and proven percutaneous procedure that is widely used to treat patients with symptomatic and asymptomatic carotid artery stenosis. The purpose of this study was to characterize the in-hospital outcomes of symptomatic and asymptomatic patients undergoing CAS at a single neurovascular center. Methods: The study was conducted as a retrospective analysis of 1158 patients (asymptomatic, n = 636; symptomatic, n = 522; male, n = 816; median age, 71 years; NASCET method, 70–99% stenosis, n = 830) who underwent CAS between May 2009 and December 2020. In-hospital neurological outcomes, adverse reactions to iodinated contrast media, acute myocardial infarction, intraprocedural complications, and access-site issues were evaluated. The primary endpoints were disabling stroke (including disabling cerebral hyperperfusion syndrome [CHS]) and all in-hospital deaths. Results: A carotid stent could not be deployed in one patient due to calcified plaques (technical failure rate of 0.09%). Four patients (0.3%) experienced in-hospital, stroke-associated death, while five patients (0.4%) died from non-stroke-related causes. All stroke-associated deaths occurred in the symptomatic group and were due to CHS. The disabling stroke rate was 0.9% overall (n = 10; 0.5% versus 1.3% in asymptomatic versus symptomatic patients, respectively). Nineteen patients (1.6%) reached the in-hospital primary endpoint. More patients in the symptomatic group achieved this endpoint than in the asymptomatic group (2.5% versus 0.9%, respectively; p = 0.060). Conclusions: An evaluation was conducted on the in-hospital outcomes of 1158 patients at a single center who underwent CAS and was performed by trained physicians who were supervised by a senior neurovascular interventionist with over 20 years of experience, confirming the excellent safety profile of this procedure with a low rate of complications. MDPI 2022-04-07 /pmc/articles/PMC9031352/ /pubmed/35456179 http://dx.doi.org/10.3390/jcm11082086 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hajiyev, Kamran
Hellstern, Victoria
Cimpoca, Alexandru
Wendl, Christina
Bäzner, Hansjörg
Henkes, Hans
von Gottberg, Philipp
Carotid Artery Stenting in Patients with Symptomatic and Asymptomatic Stenosis: In-Hospital Clinical Outcomes at a Single Neurovascular Center
title Carotid Artery Stenting in Patients with Symptomatic and Asymptomatic Stenosis: In-Hospital Clinical Outcomes at a Single Neurovascular Center
title_full Carotid Artery Stenting in Patients with Symptomatic and Asymptomatic Stenosis: In-Hospital Clinical Outcomes at a Single Neurovascular Center
title_fullStr Carotid Artery Stenting in Patients with Symptomatic and Asymptomatic Stenosis: In-Hospital Clinical Outcomes at a Single Neurovascular Center
title_full_unstemmed Carotid Artery Stenting in Patients with Symptomatic and Asymptomatic Stenosis: In-Hospital Clinical Outcomes at a Single Neurovascular Center
title_short Carotid Artery Stenting in Patients with Symptomatic and Asymptomatic Stenosis: In-Hospital Clinical Outcomes at a Single Neurovascular Center
title_sort carotid artery stenting in patients with symptomatic and asymptomatic stenosis: in-hospital clinical outcomes at a single neurovascular center
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031352/
https://www.ncbi.nlm.nih.gov/pubmed/35456179
http://dx.doi.org/10.3390/jcm11082086
work_keys_str_mv AT hajiyevkamran carotidarterystentinginpatientswithsymptomaticandasymptomaticstenosisinhospitalclinicaloutcomesatasingleneurovascularcenter
AT hellsternvictoria carotidarterystentinginpatientswithsymptomaticandasymptomaticstenosisinhospitalclinicaloutcomesatasingleneurovascularcenter
AT cimpocaalexandru carotidarterystentinginpatientswithsymptomaticandasymptomaticstenosisinhospitalclinicaloutcomesatasingleneurovascularcenter
AT wendlchristina carotidarterystentinginpatientswithsymptomaticandasymptomaticstenosisinhospitalclinicaloutcomesatasingleneurovascularcenter
AT baznerhansjorg carotidarterystentinginpatientswithsymptomaticandasymptomaticstenosisinhospitalclinicaloutcomesatasingleneurovascularcenter
AT henkeshans carotidarterystentinginpatientswithsymptomaticandasymptomaticstenosisinhospitalclinicaloutcomesatasingleneurovascularcenter
AT vongottbergphilipp carotidarterystentinginpatientswithsymptomaticandasymptomaticstenosisinhospitalclinicaloutcomesatasingleneurovascularcenter